Health Insurance MarketplaceSM, 35770-35772 [2016-13085]

Download as PDF 35770 Federal Register / Vol. 81, No. 107 / Friday, June 3, 2016 / Notices Sustainability, Tourist Opportunities, and Revived Economies of the Gulf Coast States Act of 2012 (RESTORE Act),33 U.S.C. 1321(t)(3). The Council announces the Spill Impact Component Notice of Funding Availability (NOFA). The NOFA provides guidance to eligible entities on the steps necessary to submit an SEP for approval in the first phase as required by the RESTORE Act and to complete the second phase of submitting their grant applications for individual projects and programs contained in the State’s approved SEP. Only projects contained in an approved SEP are eligible. The full text of the NOFA can be found at www.grants.gov and at https://www.restorethegulf.gov/ spill-impact-component. Will D. Spoon, Program Analyst, Gulf Coast Ecosystem Restoration Council. [FR Doc. 2016–13059 Filed 6–2–16; 8:45 am] BILLING CODE 6560–58–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–7041–N] Health Insurance MarketplaceSM, Medicare, Medicaid, and Children’s Health Insurance Program; Meeting of the Advisory Panel on Outreach and Education (APOE), June 22, 2016 Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice of meeting. AGENCY: This notice announces the new meeting of the Advisory Panel on Outreach and Education (APOE) (the Panel) in accordance with the Federal Advisory Committee Act. The Panel advises and makes recommendations to the Secretary of the U.S. Department of Health and Human Services (HHS) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on opportunities to enhance the effectiveness of Health Insurance MarketplaceSM,1 Medicare, Medicaid, and Children’s Health Insurance Program (CHIP) consumer education strategies. This meeting is open to the public. DATES: Meeting Date: Wednesday, June 22, 2016 8:30 a.m. to 4:00 p.m. eastern daylight time (e.d.t). Deadline for Meeting Registration, Presentations, Special Accommodations mstockstill on DSK3G9T082PROD with NOTICES SUMMARY: 1 Health Insurance MarketplaceSM and MarketplaceSM are service marks of the U.S. Department of Health & Human Services. VerDate Sep<11>2014 21:20 Jun 02, 2016 Jkt 238001 and Comments: Wednesday, June 8, 2016, 5:00 p.m., eastern daylight time (e.d.t.). ADDRESSES: Meeting Location: U.S. Department of Health & Human Services, Hubert H. Humphrey Building, 200 Independence Avenue SW., Room 425A, Conference Room, Washington, DC 20201. Presentations and Written Comments: Presentations and written comments should be submitted to: Abigail Huffman, Designated Federal Official (DFO), Division of Forum and Conference Development, Office of Communications, Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Mailstop S1–05–06, Baltimore, MD 21244–1850 or via email at Abigail.Huffman1@cms.hhs.gov. Registration: The meeting is open to the public, but attendance is limited to the space available. Persons wishing to attend this meeting must register at the Web site https://www.regonline.com/ apoejune2016meeting or, by contacting the DFO as listed in the FOR FURTHER INFORMATION CONTACT section of this notice, by the date listed in the DATES section of this notice. Individuals requiring sign language interpretation or other special accommodations should contact the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. FOR FURTHER INFORMATION CONTACT: Abigail Huffman, Designated Federal Official, Office of Communications, CMS, 7500 Security Boulevard, Mail Stop S1–05–06, Baltimore, MD 21244, 410–786–0897, email Abigail.Huffman1@cms.hhs.gov. Additional information about the APOE is available on the Internet at: https:// www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE.html. Press inquiries are handled through the CMS Press Office at (202) 690–6145. SUPPLEMENTARY INFORMATION: I. Background The Advisory Panel for Outreach and Education (APOE) (the Panel) is governed by the provisions of Federal Advisory Committee Act (FACA) (Pub. L. 92–463), as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of federal advisory committees. The Panel is authorized by section 1114(f) of the Social Security Act (42 U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42 U.S.C. 217a). The Secretary of the U.S. Department of Health and Human Services (HHS) (the Secretary) signed the charter establishing the Citizen’s Advisory PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Panel on Medicare Education 2 (the predecessor to the APOE) on January 21, 1999 (64 FR 7899, February 17, 1999) to advise and make recommendations to the Secretary and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on the effective implementation of national Medicare education programs, including with respect to the Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997 (Pub. L. 105–33). The Medicare Modernization Act of 2003 (MMA) (Pub. L. 108–173) expanded the existing health plan options and benefits available under the M+C program and renamed it the Medicare Advantage (MA) program. We have had substantial responsibilities to provide information to Medicare beneficiaries about the range of health plan options available and better tools to evaluate these options. The successful MA program implementation required CMS to consider the views and policy input from a variety of private sector constituents and to develop a broad range of public-private partnerships. In addition, Title I of the MMA authorized the Secretary and the Administrator of CMS (by delegation) to establish the Medicare prescription drug benefit. The drug benefit allows beneficiaries to obtain qualified prescription drug coverage. In order to effectively administer the MA program and the Medicare prescription drug benefit, we have substantial responsibilities to provide information to Medicare beneficiaries about the range of health plan options and benefits available, and to develop better tools to evaluate these plans and benefits. The Affordable Care Act (Patient Protection and Affordable Care Act, Pub. L. 111–148, and Health Care and Education Reconciliation Act of 2010, Pub. L. 111–152) expanded the availability of other options for health care coverage and enacted a number of changes to Medicare as well as to Medicaid and the Children’s Health Insurance Program (CHIP). Qualified individuals and qualified employers are now able to purchase private health insurance coverage through competitive marketplaces, called Affordable Insurance Exchanges (we also call an Exchange a Health Insurance MarketplaceSM or MarketplaceSM). In order to effectively implement and administer these changes, we must 2 We note that the Citizen’s Advisory Panel on Medicare Education is also referred to as the Advisory Panel on Medicare Education (65 FR 4617). The name was updated in the Second Amended Charter approved on July 24, 2000. E:\FR\FM\03JNN1.SGM 03JNN1 mstockstill on DSK3G9T082PROD with NOTICES Federal Register / Vol. 81, No. 107 / Friday, June 3, 2016 / Notices provide information to consumers, providers, and other stakeholders through education and outreach programs regarding how existing programs will change and the expanded range of health coverage options available, including private health insurance coverage through the MarketplaceSM. The APOE (the Panel) allows us to consider a broad range of views and information from interested audiences in connection with this effort and to identify opportunities to enhance the effectiveness of education strategies concerning the Affordable Care Act. The scope of this panel also includes advising on issues pertaining to the education of providers and stakeholders with respect to the Affordable Care Act and certain provisions of the Health Information Technology for Economic and Clinical Health (HITECH) Act enacted as part of the American Recovery and Reinvestment Act of 2009 (ARRA). On January 21, 2011, the Panel’s charter was renewed and the Panel was renamed the Advisory Panel for Outreach and Education. The Panel’s charter was most recently renewed on January 21, 2015, and will terminate on January 21, 2017 unless renewed by appropriate action. Under the current charter, the APOE will advise the Secretary and the Administrator on optimal strategies for the following: • Developing and implementing education and outreach programs for individuals enrolled in, or eligible for, Medicare, Medicaid, and the Children’s Health Insurance Program (CHIP), or coverage available through the Health Insurance MarketplaceSM. • Enhancing the federal government’s effectiveness in informing Health Insurance MarketplaceSM, Medicare, Medicaid, and CHIP consumers, issuers, providers, and stakeholders, through education and outreach programs, on issues regarding these programs, including the appropriate use of publicprivate partnerships to leverage the resources of the private sector in educating beneficiaries, providers, and stakeholders. • Expanding outreach to vulnerable and underserved communities, including racial and ethnic minorities, in the context of Health Insurance MarketplaceSM, Medicare, Medicaid, and CHIP education programs. • Assembling and sharing an information base of ‘‘best practices’’ for helping consumers evaluate health coverage options. • Building and leveraging existing community infrastructures for information, counseling, and assistance. VerDate Sep<11>2014 21:20 Jun 02, 2016 Jkt 238001 • Drawing the program link between outreach and education, promoting consumer understanding of health care coverage choices, and facilitating consumer selection/enrollment, which in turn support the overarching goal of improved access to quality care, including prevention services, envisioned under the Affordable Care Act. The current members of the Panel are: Kellan Baker, Associate Director, Center for American Progress; Robert Blancato, President, Matz, Blancato & Associates; Dale Blasier, Professor of Orthopedic Surgery, Department of Orthopedics, Arkansas Children’s Hospital; Deborah Britt, Executive Director of Community & Public Relations, Piedmont Fayette Hospital; Deena Chisolm, Associate Professor of Pediatrics & Public Health, The Ohio State University, Nationwide Children’s Hospital; Josephine DeLeon, Director, Anti-Poverty Initiatives, Catholic Charities of California; Robert Espinoza, Vice President of Policy, Paraprofessional Healthcare Institute; Jennifer Gross, Manager of Political Field Operations, Planned Parenthood of Montana; Louise Scherer Knight, Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Miriam Mobley-Smith, Dean, Director of Strategic Alliances, Pharmacy Technician Certification Board; Roanne Osborne-Gaskin, M.D., Senior Medical Director, MDWise, Inc.; Cathy Phan, Outreach and Education Coordinator, Asian American Health Coalition DBA HOPE Clinic; Kamilah Pickett, Litigation Support, Independent Contractor; Brendan Riley, Outreach and Enrollment Coordinator, NC Community Health Center Association; Alvia Siddiqi, Medicaid Managed Care Community Network (MCCN) Medical Director, Advocate Physician Partners, Carla Smith, Executive Vice President, Healthcare Information and Management Systems Society (HIMSS); Tobin Van Ostern, Vice President and Co-Founder, Young Invincible Advisors; and Paula Villescaz, Senior Consultant, Assembly Health Committee, California State Legislature. II. Meeting Agenda In accordance with section 10(a) of the FACA, this notice announces a meeting of the APOE. The agenda for the June 22, 2016 meeting will include the following: • Welcome and listening session with CMS leadership • Recap of the previous (January 13, 2016) meeting • Affordable Care Act initiatives • An opportunity for public comment PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 35771 • Meeting summary, review of recommendations, and next steps Individuals or organizations that wish to make a 5-minute oral presentation on an agenda topic should submit a written copy of the oral presentation to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. The number of oral presentations may be limited by the time available. Individuals not wishing to make an oral presentation may submit written comments to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. III. Security, Building, and Parking Guidelines This meeting will be held in a federal government building; therefore, federal security measures are applicable. The Real ID Act, enacted in 2005, establishes minimum standards for the issuance of state-issued driver’s licenses and identification (ID) cards. It prohibits Federal agencies from accepting an official driver’s license or ID card from a state unless the Department of Homeland Security determines that the state meets these standards. Beginning October 2015, photo IDs (such as a valid driver’s license) issued by a state or territory not in compliance with the Real ID Act will not be accepted as identification to enter Federal buildings. Visitors from these states/territories will need to provide alternative proof of identification (such as a valid passport) to gain entrance into CMS buildings. The current list of states from which a Federal agency may accept driver’s licenses for an official purpose is found at https://www.dhs.gov/real-idenforcement-brief. We recommend that confirmed registrants arrive reasonably early, but no earlier than 45 minutes prior to the start of the meeting, to allow additional time to clear security. Security measures include the following: • Presentation of government issued photographic identification to the Federal Protective Service or Guard Service personnel. • Inspection of vehicle’s interior and exterior (this includes engine and trunk inspection) at the entrance to the grounds. Parking permits and instructions will be issued after the vehicle inspection. • Inspection, via metal detector or other applicable means, of all persons entering the building. We note that all items brought into CMS, whether personal or for the purpose of presentation or to support a presentation, are subject to inspection. E:\FR\FM\03JNN1.SGM 03JNN1 35772 Federal Register / Vol. 81, No. 107 / Friday, June 3, 2016 / Notices We cannot assume responsibility for coordinating the receipt, transfer, transport, storage, set up, safety, or timely arrival of any personal belongings or items used for presentation or to support a presentation. Note: Individuals who are not registered in advance will not be permitted to enter the building and will be unable to attend the meeting. The public may not enter the building earlier than 45 minutes prior to the convening of the meeting. All visitors must be escorted in areas other than the lower and first floor levels in the Central Building. Authority: Sec. 222 of the Public Health Service Act (42 U.S.C. 217a) and sec. 10(a) of Pub. L. 92–463 (5 U.S.C. App. 2, sec. 10(a) and 41 CFR 102–3). Dated: May 26, 2016. Andrew M. Slavitt, Acting Administrator, Centers for Medicare & Medicaid Services. [FR Doc. 2016–13085 Filed 6–2–16; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–1666–N] Medicare, Medicaid, and Children’s Health Insurance Programs; Announcement of the Advisory Panel on Clinical Diagnostic Laboratory Tests Meeting on July 18, 2016 Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice. AGENCY: This notice announces the next public meeting date of the Advisory Panel on Clinical Diagnostic Laboratory Tests (the Panel) on Monday, July 18, 2016. The purpose of the Panel is to advise the Secretary of the Department of Health and Human Services (DHHS) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) (the Administrator) on issues related to clinical diagnostic laboratory tests. DATES: Meeting Date: The meeting of the Panel is scheduled for Monday, July 18, 2016 beginning at 9:00 a.m., Eastern Daylight Time (EDT). The morning session will be held jointly with the Public Meeting on New and Reconsidered Clinical Diagnostic Laboratory Test Codes for the Clinical Laboratory Fee Schedule (CLFS) for Calendar Year (CY) 2017 (the 2016 mstockstill on DSK3G9T082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 21:20 Jun 02, 2016 Jkt 238001 Laboratory Public Meeting) (see 81 FR 29863, May 13, 2016 for notice of the 2016 Laboratory Public Meeting). During the afternoon session, the Panel will deliberate and make recommendations regarding the new and reconsidered laboratory codes for CY 2017. The Panel may also hear public presentations on additional issues concerning the CY 2017 CLFS that are designated in the Panel’s charter and specified in the Panel meeting agenda for the afternoon session. Meeting Registration: The public may attend the Panel meeting in-person, view via webcast, or listen via teleconference. Beginning Monday, June 6, 2016 and ending Friday, July 1, 2016 at 5:00 p.m. EDT, registration to attend the Panel meeting in-person may be completed online at https://cms.gov/ Regulations-and-Guidance/Guidance/ FACA/AdvisoryPanelonClinical DiagnosticLaboratoryTests.html. On this Web page, under ‘‘Related Links,’’ double-click the ‘‘Clinical Diagnostic Laboratory Tests FACA Panel Meeting Registration’’ link and enter the required information. All the following information must be submitted when registering: • Name. • Company name. • Address. • Email addresses. Note: Participants who do not plan to attend the Panel meeting in-person on July 18, 2016 should not register. No registration is required for participants who plan to view the Panel meeting via webcast or listen via teleconference. Participants planning to attend only the morning session which includes the 2016 Laboratory Public Meeting, or both the morning and afternoon sessions, should register only once, for the 2016 Laboratory Public Meeting (see instructions for registering for the 2016 Laboratory Public Meeting at 81 FR 29863). Participants planning to attend only the afternoon session of the Panel meeting must register using the above link and instructions. Presenter Registration and Submission of Presentations and Comments: In the morning session only, we are interested in in-person presentations concerning the payment methodologies for new or reconsidered laboratory codes. The instructions for submitting such comments and presentations are also included in 2016 Laboratory Public Meeting notice (81 FR 29863). Although these comments and presentations will be made during the morning joint session of the 2016 Laboratory Public Meeting and Panel Meeting, the Panel may wish to ask follow-up questions to presenters at the afternoon session of the Panel Meeting. As previously mentioned, additional issues concerning the calendar year (CY) PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 2017 clinical laboratory fee schedule (CLFS) that are designated in the Panel’s charter and specified in the meeting agenda, may also be discussed at the afternoon session of the Panel meeting. Any such issues to be discussed will be specified in the Panel meeting agenda, to be published approximately 3 weeks before the meeting (A preliminary agenda is described in section II. of this notice.) Should issues be added to the agenda, we would be interested in public comments or presentations related to those issues. The comments and presentations should not address issues not specified in the agenda for the Panel meeting. The deadline to register to be a presenter and to submit written presentations for agenda items for the Panel’s afternoon session (that is, presentations on issues other than payment for new and reconsidered laboratory codes for CY 2017) is 5:00 p.m. EDT July 1, 2016. Presenters may register by email by contacting the person listed in the FOR FURTHER INFORMATION CONTACT section of this notice. Presentations should be sent via email to the same person’s email address. Meeting Location, Webcast, and Teleconference: The Panel meetings will be held in the Auditorium of the CMS, Central Office, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. Alternately, the public may either view the Panel meetings via a webcast or listen by teleconference. During the scheduled Panel meeting, webcasting is accessible online at https://cms.gov/live. Teleconference dial-in information will appear on the final Panel meeting agenda, which will be posted on the CMS Web site when available at https:// cms.gov/Regulations-and-Guidance/ Guidance/FACA/AdvisoryPanelon ClinicalDiagnosticLaboratoryTests.html. Meeting Format: This Panel meeting is open to the public. The on-site checkin for visitors will be held from 8:30 a.m. to 9:00 a.m. on Monday, July 18, 2016, preceding the morning session of the 2016 Laboratory Public Meeting, and again at 12:30 p.m. for visitors attending only the Panel meeting (afternoon session). During the morning session, the Panel, along with the public, will hear and pose questions to presenters recommending crosswalks or gapfilling for new and reconsidered laboratory codes for calendar year (CY) 2017. During the afternoon session, the Panel will deliberate and make recommendations to the Secretary of HHS and the Acting Administrator of CMS regarding crosswalks or gapfilling for new and reconsidered laboratory codes discussed during the morning E:\FR\FM\03JNN1.SGM 03JNN1

Agencies

[Federal Register Volume 81, Number 107 (Friday, June 3, 2016)]
[Notices]
[Pages 35770-35772]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-13085]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-7041-N]


Health Insurance Marketplace\SM\, Medicare, Medicaid, and 
Children's Health Insurance Program; Meeting of the Advisory Panel on 
Outreach and Education (APOE), June 22, 2016

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the new meeting of the Advisory Panel on 
Outreach and Education (APOE) (the Panel) in accordance with the 
Federal Advisory Committee Act. The Panel advises and makes 
recommendations to the Secretary of the U.S. Department of Health and 
Human Services (HHS) and the Administrator of the Centers for Medicare 
& Medicaid Services (CMS) on opportunities to enhance the effectiveness 
of Health Insurance Marketplace\SM\,\1\ Medicare, Medicaid, and 
Children's Health Insurance Program (CHIP) consumer education 
strategies. This meeting is open to the public.
---------------------------------------------------------------------------

    \1\ Health Insurance Marketplace\SM\ and Marketplace\SM\ are 
service marks of the U.S. Department of Health & Human Services.

DATES: Meeting Date: Wednesday, June 22, 2016 8:30 a.m. to 4:00 p.m. 
eastern daylight time (e.d.t).
    Deadline for Meeting Registration, Presentations, Special 
Accommodations and Comments: Wednesday, June 8, 2016, 5:00 p.m., 
eastern daylight time (e.d.t.).

ADDRESSES: Meeting Location: U.S. Department of Health & Human 
Services, Hubert H. Humphrey Building, 200 Independence Avenue SW., 
Room 425A, Conference Room, Washington, DC 20201.
    Presentations and Written Comments: Presentations and written 
comments should be submitted to: Abigail Huffman, Designated Federal 
Official (DFO), Division of Forum and Conference Development, Office of 
Communications, Centers for Medicare & Medicaid Services, 7500 Security 
Boulevard, Mailstop S1-05-06, Baltimore, MD 21244-1850 or via email at 
Abigail.Huffman1@cms.hhs.gov.
    Registration: The meeting is open to the public, but attendance is 
limited to the space available. Persons wishing to attend this meeting 
must register at the Web site https://www.regonline.com/apoejune2016meeting or, by contacting the DFO as listed in the FOR 
FURTHER INFORMATION CONTACT section of this notice, by the date listed 
in the DATES section of this notice. Individuals requiring sign 
language interpretation or other special accommodations should contact 
the DFO at the address listed in the ADDRESSES section of this notice 
by the date listed in the DATES section of this notice.

FOR FURTHER INFORMATION CONTACT: Abigail Huffman, Designated Federal 
Official, Office of Communications, CMS, 7500 Security Boulevard, Mail 
Stop S1-05-06, Baltimore, MD 21244, 410-786-0897, email 
Abigail.Huffman1@cms.hhs.gov. Additional information about the APOE is 
available on the Internet at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE.html. Press inquiries are handled through 
the CMS Press Office at (202) 690-6145.

SUPPLEMENTARY INFORMATION: 

I. Background

    The Advisory Panel for Outreach and Education (APOE) (the Panel) is 
governed by the provisions of Federal Advisory Committee Act (FACA) 
(Pub. L. 92-463), as amended (5 U.S.C. Appendix 2), which sets forth 
standards for the formation and use of federal advisory committees. The 
Panel is authorized by section 1114(f) of the Social Security Act (42 
U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42 
U.S.C. 217a).
    The Secretary of the U.S. Department of Health and Human Services 
(HHS) (the Secretary) signed the charter establishing the Citizen's 
Advisory Panel on Medicare Education \2\ (the predecessor to the APOE) 
on January 21, 1999 (64 FR 7899, February 17, 1999) to advise and make 
recommendations to the Secretary and the Administrator of the Centers 
for Medicare & Medicaid Services (CMS) on the effective implementation 
of national Medicare education programs, including with respect to the 
Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997 
(Pub. L. 105-33).
---------------------------------------------------------------------------

    \2\ We note that the Citizen's Advisory Panel on Medicare 
Education is also referred to as the Advisory Panel on Medicare 
Education (65 FR 4617). The name was updated in the Second Amended 
Charter approved on July 24, 2000.
---------------------------------------------------------------------------

    The Medicare Modernization Act of 2003 (MMA) (Pub. L. 108-173) 
expanded the existing health plan options and benefits available under 
the M+C program and renamed it the Medicare Advantage (MA) program. We 
have had substantial responsibilities to provide information to 
Medicare beneficiaries about the range of health plan options available 
and better tools to evaluate these options. The successful MA program 
implementation required CMS to consider the views and policy input from 
a variety of private sector constituents and to develop a broad range 
of public-private partnerships.
    In addition, Title I of the MMA authorized the Secretary and the 
Administrator of CMS (by delegation) to establish the Medicare 
prescription drug benefit. The drug benefit allows beneficiaries to 
obtain qualified prescription drug coverage. In order to effectively 
administer the MA program and the Medicare prescription drug benefit, 
we have substantial responsibilities to provide information to Medicare 
beneficiaries about the range of health plan options and benefits 
available, and to develop better tools to evaluate these plans and 
benefits.
    The Affordable Care Act (Patient Protection and Affordable Care 
Act, Pub. L. 111-148, and Health Care and Education Reconciliation Act 
of 2010, Pub. L. 111-152) expanded the availability of other options 
for health care coverage and enacted a number of changes to Medicare as 
well as to Medicaid and the Children's Health Insurance Program (CHIP). 
Qualified individuals and qualified employers are now able to purchase 
private health insurance coverage through competitive marketplaces, 
called Affordable Insurance Exchanges (we also call an Exchange a 
Health Insurance Marketplace\SM\ or Marketplace\SM\). In order to 
effectively implement and administer these changes, we must

[[Page 35771]]

provide information to consumers, providers, and other stakeholders 
through education and outreach programs regarding how existing programs 
will change and the expanded range of health coverage options 
available, including private health insurance coverage through the 
Marketplace\SM\. The APOE (the Panel) allows us to consider a broad 
range of views and information from interested audiences in connection 
with this effort and to identify opportunities to enhance the 
effectiveness of education strategies concerning the Affordable Care 
Act.
    The scope of this panel also includes advising on issues pertaining 
to the education of providers and stakeholders with respect to the 
Affordable Care Act and certain provisions of the Health Information 
Technology for Economic and Clinical Health (HITECH) Act enacted as 
part of the American Recovery and Reinvestment Act of 2009 (ARRA).
    On January 21, 2011, the Panel's charter was renewed and the Panel 
was renamed the Advisory Panel for Outreach and Education. The Panel's 
charter was most recently renewed on January 21, 2015, and will 
terminate on January 21, 2017 unless renewed by appropriate action.
    Under the current charter, the APOE will advise the Secretary and 
the Administrator on optimal strategies for the following:
     Developing and implementing education and outreach 
programs for individuals enrolled in, or eligible for, Medicare, 
Medicaid, and the Children's Health Insurance Program (CHIP), or 
coverage available through the Health Insurance Marketplace\SM\.
     Enhancing the federal government's effectiveness in 
informing Health Insurance Marketplace\SM\, Medicare, Medicaid, and 
CHIP consumers, issuers, providers, and stakeholders, through education 
and outreach programs, on issues regarding these programs, including 
the appropriate use of public-private partnerships to leverage the 
resources of the private sector in educating beneficiaries, providers, 
and stakeholders.
     Expanding outreach to vulnerable and underserved 
communities, including racial and ethnic minorities, in the context of 
Health Insurance Marketplace\SM\, Medicare, Medicaid, and CHIP 
education programs.
     Assembling and sharing an information base of ``best 
practices'' for helping consumers evaluate health coverage options.
     Building and leveraging existing community infrastructures 
for information, counseling, and assistance.
     Drawing the program link between outreach and education, 
promoting consumer understanding of health care coverage choices, and 
facilitating consumer selection/enrollment, which in turn support the 
overarching goal of improved access to quality care, including 
prevention services, envisioned under the Affordable Care Act.
    The current members of the Panel are: Kellan Baker, Associate 
Director, Center for American Progress; Robert Blancato, President, 
Matz, Blancato & Associates; Dale Blasier, Professor of Orthopedic 
Surgery, Department of Orthopedics, Arkansas Children's Hospital; 
Deborah Britt, Executive Director of Community & Public Relations, 
Piedmont Fayette Hospital; Deena Chisolm, Associate Professor of 
Pediatrics & Public Health, The Ohio State University, Nationwide 
Children's Hospital; Josephine DeLeon, Director, Anti-Poverty 
Initiatives, Catholic Charities of California; Robert Espinoza, Vice 
President of Policy, Paraprofessional Healthcare Institute; Jennifer 
Gross, Manager of Political Field Operations, Planned Parenthood of 
Montana; Louise Scherer Knight, Director, The Sidney Kimmel 
Comprehensive Cancer Center at Johns Hopkins; Miriam Mobley-Smith, 
Dean, Director of Strategic Alliances, Pharmacy Technician 
Certification Board; Roanne Osborne-Gaskin, M.D., Senior Medical 
Director, MDWise, Inc.; Cathy Phan, Outreach and Education Coordinator, 
Asian American Health Coalition DBA HOPE Clinic; Kamilah Pickett, 
Litigation Support, Independent Contractor; Brendan Riley, Outreach and 
Enrollment Coordinator, NC Community Health Center Association; Alvia 
Siddiqi, Medicaid Managed Care Community Network (MCCN) Medical 
Director, Advocate Physician Partners, Carla Smith, Executive Vice 
President, Healthcare Information and Management Systems Society 
(HIMSS); Tobin Van Ostern, Vice President and Co-Founder, Young 
Invincible Advisors; and Paula Villescaz, Senior Consultant, Assembly 
Health Committee, California State Legislature.

II. Meeting Agenda

    In accordance with section 10(a) of the FACA, this notice announces 
a meeting of the APOE. The agenda for the June 22, 2016 meeting will 
include the following:

 Welcome and listening session with CMS leadership
 Recap of the previous (January 13, 2016) meeting
 Affordable Care Act initiatives
 An opportunity for public comment
 Meeting summary, review of recommendations, and next steps

    Individuals or organizations that wish to make a 5-minute oral 
presentation on an agenda topic should submit a written copy of the 
oral presentation to the DFO at the address listed in the ADDRESSES 
section of this notice by the date listed in the DATES section of this 
notice. The number of oral presentations may be limited by the time 
available. Individuals not wishing to make an oral presentation may 
submit written comments to the DFO at the address listed in the 
ADDRESSES section of this notice by the date listed in the DATES 
section of this notice.

III. Security, Building, and Parking Guidelines

    This meeting will be held in a federal government building; 
therefore, federal security measures are applicable. The Real ID Act, 
enacted in 2005, establishes minimum standards for the issuance of 
state-issued driver's licenses and identification (ID) cards. It 
prohibits Federal agencies from accepting an official driver's license 
or ID card from a state unless the Department of Homeland Security 
determines that the state meets these standards. Beginning October 
2015, photo IDs (such as a valid driver's license) issued by a state or 
territory not in compliance with the Real ID Act will not be accepted 
as identification to enter Federal buildings. Visitors from these 
states/territories will need to provide alternative proof of 
identification (such as a valid passport) to gain entrance into CMS 
buildings. The current list of states from which a Federal agency may 
accept driver's licenses for an official purpose is found at https://www.dhs.gov/real-id-enforcement-brief. We recommend that confirmed 
registrants arrive reasonably early, but no earlier than 45 minutes 
prior to the start of the meeting, to allow additional time to clear 
security. Security measures include the following:
     Presentation of government issued photographic 
identification to the Federal Protective Service or Guard Service 
personnel.
     Inspection of vehicle's interior and exterior (this 
includes engine and trunk inspection) at the entrance to the grounds. 
Parking permits and instructions will be issued after the vehicle 
inspection.
     Inspection, via metal detector or other applicable means, 
of all persons entering the building. We note that all items brought 
into CMS, whether personal or for the purpose of presentation or to 
support a presentation, are subject to inspection.

[[Page 35772]]

We cannot assume responsibility for coordinating the receipt, transfer, 
transport, storage, set up, safety, or timely arrival of any personal 
belongings or items used for presentation or to support a presentation.
    Note: Individuals who are not registered in advance will not be 
permitted to enter the building and will be unable to attend the 
meeting. The public may not enter the building earlier than 45 minutes 
prior to the convening of the meeting.
    All visitors must be escorted in areas other than the lower and 
first floor levels in the Central Building.

    Authority:  Sec. 222 of the Public Health Service Act (42 U.S.C. 
217a) and sec. 10(a) of Pub. L. 92-463 (5 U.S.C. App. 2, sec. 10(a) 
and 41 CFR 102-3).

    Dated: May 26, 2016.
Andrew M. Slavitt,
Acting Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2016-13085 Filed 6-2-16; 8:45 am]
 BILLING CODE 4120-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.